Menu
Back to User profile » Professor Qosay Al-Balas
Papers published by Professor Qosay Al-Balas:
Unraveling Potential Glyoxalase-I Inhibitors Utilizing Structure-Based Drug Design Techniques
Fetian MH, Al-Balas QA
Advances and Applications in Bioinformatics and Chemistry 2024, 17:21-32
Published Date: 5 February 2024
Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors
Audat SA, Al-Balas QA, Al-Oudat BA, Athamneh MJ, Bryant-Friedrich A
Drug Design, Development and Therapy 2022, 16:873-885
Published Date: 28 March 2022
Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators
Al-Oudat BA, Alqudah MA, Audat SA, Al-Balas QA, El-Elimat T, Hassan MA, Frhat IN, Azaizeh MM
Drug Design, Development and Therapy 2019, 13:423-433
Published Date: 22 January 2019
In vivo antimicrobial activity of the hybrid peptide H4: a follow-up study
Almaaytah A, Albalas Q, Alzoubi KH
Infection and Drug Resistance 2018, 11:1383-1386
Published Date: 3 September 2018
Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides
Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH
Infection and Drug Resistance 2018, 11:835-847
Published Date: 1 June 2018
Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria
Almaaytah A, Mohammed GK, Abualhaijaa A, Al-Balas Q
Drug Design, Development and Therapy 2017, 11:3159-3170
Published Date: 3 November 2017
Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides
Almaaytah A, Ajingi Y, Abualhaijaa A, Tarazi S, Alshar’i N, Al-Balas Q
Infection and Drug Resistance 2017, 10:1-17
Published Date: 29 December 2016
Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
Al-Balas QA, Hassan MA, Al-Shar’i NA, Mhaidat NM, Almaaytah AM, Al-Mahasneh FM, Isawi IH
Drug Design, Development and Therapy 2016, 10:2623-2629
Published Date: 17 August 2016
Potassium-3-beta-hydroxy-20-oxopregn-5-en-17-alpha-yl sulfate: a novel inhibitor of 78 kDa glucose-regulated protein
Mhaidat NM, Al-Balas QA, Alzoubi KH, AlEjielat RF
OncoTargets and Therapy 2016, 9:627-634
Published Date: 3 February 2016
Synthesis, antimicrobial and in vitro antitumor activities of a series of 1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives
Mhaidat NM, Al-Smadi M, Al-Momani F, Alzoubi KH, Mansi I, Al-Balas Q
Drug Design, Development and Therapy 2015, 9:3645-3652
Published Date: 16 July 2015
Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme
Al-Balas QA, Sowaileh MF, Hassan MA, Qandil AM, Alzoubi KH, Mhaidat NM, Almaaytah AM, Khabour OF
Drug Design, Development and Therapy 2014, 8:129-163
Published Date: 16 January 2014